Corporate Banner
Satellite Banner
ADME Tox
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Shimadzu UK Launches LCMS-8080

Published: Monday, December 31, 2012
Last Updated: Monday, December 31, 2012
Bookmark and Share
Offers best-in-class sensitivity, high quality data and fast cycle times.

Shimadzu UK has launched a high-end liquid chromatography mass spectrometer - the LCMS-8080 - which delivers best-in-class sensitivity, high quality data and fast cycle times.

An extension of its Ultra Fast Mass Spectrometry (UFMS) range, the new model’s high speed capabilities increase productivity in the laboratory by delivering accurate measurements, first time.

Ideal for users requiring information rich analyses, the LCMS-8080 can be used across a wide range of applications including food safety testing, drugs of abuse screening as well as in clinical, environmental and ADME laboratories.

The instrument delivers high quality and accurate data over long periods of use due to its simple and rapid method development.

The innovative Coaxial Hot Gas Desolvation source is fundamental in delivering the LCMS-8080’s enhanced sensitivity as it focuses the ion plume and improves ionization efficiency.

This is further enhanced by Hot Source Induced Desolvation which removes solvent noise, followed by high performance pumping and a multi-orthogonal inlet.

The LCMS-8080’s class-leading sensitivity allows accurate quantitation of low level analytes Plus, the model provides outstanding ruggedness when measuring target compounds in complex matrices.

Its compact footprint frees up the use of costly lab space, while its robust characteristics increase uptime by reducing instrument down time.

Shimadzu offers prepackaged methods to enable rapid installation of the LCMS-8080. This means that individual components can easily be reused when new methods have been developed, which reduces the amount of rework necessary and boosts productivity.

Shimadzu’s software is purpose built for chromatography and quantitation, providing a single platform for Shimadzu’s liquid chromatography (LC), gas chromatography (GC), LCMS and GCMS.

The intuitive and unified operation flow and new functionalities enable more efficient data processing. Analyses which use both GC-MS/MS and LC-MS/MS for the same sample, such as multi-target quantitative analysis in food safety testing, benefit from the unified graphical user interface of software which reduces training needs across the laboratory and minimizes the total cost of ownership.

The LCMS-8080 is compatible with Nexera UHPLC which offers high carryover specifications and the highest pressure rating of any UHPLC.

Users can be confident in the analyses as the high end instrument delivers offers excellent stability and reliability in data acquisition, even when rapidly switching the ionization polarity.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Breakthrough Flu Vaccine Inhibited by Pre-existing Antibodies
Universal truths – how existing antibodies are sabotaging the most promising new human flu vaccines.
Gene Therapy for Metabolic Liver Diseases
Researchers have tested gene therapy in pigs from hereditary tyrosinemia type 1, with corrected liver cells being transplanted into the diseased liver.
Zika Vaccine Candidates Show Promise
Two experimental vaccines have shown promise against a major viral strain responsible for the Brazilian Zika outbreak.
Testing Nanoparticle Drug Delivery in Dogs
Scientists have tested a nanoparticle drug delivery against bone cancer in dogs with promising results.
Targeting Autoimmunity
Researchers have developed a strategy to treat a rare autoimmune disease which could lead to treatments of other autoimmune diseases.
Colon Cancer Blocked in Mice
Case Western Reserve University Researchers block common type of colon cancer tumour in mice, laying groundwork for human clinical trial.
Protein Nanocages Could Improve Drug Design and Delivery
HHMI scientists have designed and built 10 large protein icosahedra that are similar to viral capsids that carry viral DNA.
Development in Preventing Macular Degeneration
Following macular degeneration insight, promising drugs to prevent vision loss have been identified.
Improving Tumour Therapy with Nanoparticles
UHN nanoparticle called PEARLs is a promising utilisation of photo-thermal therapy for cancer treatment.
New Antidepressant Treatment Discovered
Scientists have demonstrated how gene therapy could lead to new treatments for depression.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!